Search Results 461-470 of 4347 for 搜索留痕平台咨询邮箱：lgooxc@hotmail.com

  1. Lobular carcinoma in situ (LCIS) - Doctors and departments - Mayo Clinic

    If a breast biopsy reveals you have LCIS, your risk of breast cancer is increased. Learn how you can reduce your risk through medications and other ...

  2. Contact - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    Tumor Development, Immunology & Progression Lab of Peter Storz, Ph.D., at Mayo Clinic: Contact Dr. Storz about cancer research, cell signaling & pathways.

  3. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  4. Center for Clinical and Translational Science (CCaTS)

    Contact · Rural Health Research Core · Mayo Clinic · 200 First St. SW · Rochester, MN 55905 · Email: ruralhealthcore@mayo.edu.

  5. Education and training - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    Robert C. Huebert, M.D.. Mayo Clinic 200 First St. SW Rochester, MN 55905; Phone: 507-284-1006. Email inquiries to Debbie J. Hintz ...

  6. Contact - Liquid Biopsy and Translational Immunogenomics: Aadel A. Chaudhuri - Mayo Clinic Research

    Andrea M. McMahon, M.B.A. · Program Manager, Research Operations · Mayo Clinic · 200 First St. SW · Rochester, MN 55905 · Email: mcmahon.andrea@mayo.edu ...

  7. A Study to Assess Neuroinflammation in Epileptic Tissue Immediately Prior to Surgical Resection Using Intraoperative Brain Microdialysis - Mayo Clinic

    The purpose of this study is to measure the space and time characteristics of inflammatory mediator release in response to induced epileptiform activity in ASD- ...

  8. Lobular carcinoma in situ (LCIS) - Doctors and departments - Mayo Clinic

    If a breast biopsy reveals you have LCIS, your risk of breast cancer is increased. Learn how you can reduce your risk through medications and other ...

  9. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

  10. Data collection, processing and analysis support - Structural Biology Core - Mayo Clinic Research Core Facilities

    Mayo Clinic's Structural Biology Core offers access to a graphics processing unit-based high-performance computing cluster and software for cryoEM data ...